Literature DB >> 14581672

Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons.

R S Wilson1, J A Schneider, J L Bienias, S E Arnold, D A Evans, D A Bennett.   

Abstract

BACKGROUND: Depressive symptoms in old age have been associated with risk of Alzheimer disease (AD), but it is uncertain whether they are an independent risk factor for disease or an early clinical sign of its underlying pathology.
METHODS: A group of 130 older Catholic nuns, priests, and brothers underwent detailed annual clinical evaluations and brain autopsy at death. The evaluations included administration of a modified 10-item Center for Epidemiologic Studies Depression Scale (CES-D) and 19 cognitive performance tests and clinical classification of dementia and AD. On postmortem examination, neuritic plaques, diffuse plaques, and neurofibrillary tangles in tissue samples from four cortical regions were counted, and a previously established composite measure of cortical plaque and tangle density (range 0 to 2.98) was derived. All analyses were adjusted for age, sex, and education.
RESULTS: Participants reported a mean 1.5 depressive symptoms (SD 1.6) on the CES-D scale averaged across evaluations. In a logistic regression model, the odds of clinically diagnosed AD proximate to death increased by 1.33 (95% CI 1.01 to 1.76) for each depressive symptom and by 8.41 (95% CI 3.49 to 20.26) for each unit on the composite measure of pathology. In subsequent analyses, depressive symptoms were not related to level of pathology and did not modify the relation of pathology to clinical AD. In a series of linear regression models that controlled for pathology, depressive symptoms were related to level of cognitive function proximate to death and did not modify the association of pathology with cognition.
CONCLUSION: The association of depressive symptoms with clinical AD and cognitive impairment appears to be independent of cortical plaques and tangles.

Entities:  

Mesh:

Year:  2003        PMID: 14581672     DOI: 10.1212/01.wnl.0000092914.04345.97

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  37 in total

1.  Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans.

Authors:  Ainie Soetanto; Robert S Wilson; Konrad Talbot; Ashley Un; Julie A Schneider; Mark Sobiesk; Jeremiah Kelly; Sue Leurgans; David A Bennett; Steven E Arnold
Journal:  Arch Gen Psychiatry       Date:  2010-05

2.  Clinicopathological correlates of depression in early Alzheimer's disease in the NACC.

Authors:  Sarah T McCutcheon; Dingfen Han; Juan Troncoso; Vassilis E Koliatsos; Marilyn Albert; Constantine G Lyketsos; Jeannie-Marie S Leoutsakos
Journal:  Int J Geriatr Psychiatry       Date:  2016-02-14       Impact factor: 3.485

3.  Where vascular meets neurodegenerative disease.

Authors:  Julie A Schneider; David A Bennett
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

Review 4.  Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project.

Authors:  S Negash; D A Bennett; R S Wilson; J A Schneider; S E Arnold
Journal:  Curr Alzheimer Res       Date:  2011-06       Impact factor: 3.498

5.  Alzheimer's disease pathology does not mediate the association between depressive symptoms and subsequent cognitive decline.

Authors:  Donald R Royall; Raymond F Palmer
Journal:  Alzheimers Dement       Date:  2012-11-13       Impact factor: 21.566

6.  Organic bases of late-life depression: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2013-01-25       Impact factor: 3.575

7.  Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis.

Authors:  Raymond L Ownby; Elizabeth Crocco; Amarilis Acevedo; Vineeth John; David Loewenstein
Journal:  Arch Gen Psychiatry       Date:  2006-05

8.  Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people.

Authors:  D A Bennett; J A Schneider; R S Wilson; J L Bienias; E Berry-Kravis; S E Arnold
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

9.  Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons.

Authors:  Patricia A Boyle; Aron S Buchman; Robert S Wilson; Sue E Leurgans; David A Bennett
Journal:  Arch Neurol       Date:  2009-11

10.  APOE-epsilon4, depressive symptoms, and cognitive decline in Chinese older adults: Singapore Longitudinal Aging Studies.

Authors:  Mathew Niti; Keng-Bee Yap; Ee-Heok Kua; Tze-Pin Ng
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-30       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.